Compile Data Set for Download or QSAR
Report error Found 464 of ic50 data for polymerid = 10768
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM699308(Synthesis of N-((3S, 14S, 17aS, 18aR, 18bS)-3-cyan...)
Affinity DataIC50: 16nMAssay Description:An objective of this experiment is to detect the in vitro inhibitory activity against Mpro of the compound of the present disclosure.Experimental mat...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM50208940(5-bromopyridin-3-yl furan-2-carboxylate | 5-bromo-...)
Affinity DataIC50: 50nMAssay Description:Inhibition of SARS coronavirus 3C-like proteaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM32805(CHEMBL222840 | SMR000114552 | MLS000594516 | (5-ch...)
Affinity DataIC50: 60nMAssay Description:Inhibition of SARS coronavirus 3C-like proteaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM50208942(5-chloropyridin-3-yl-5-(4-chlorophenyl)furan-2-car...)
Affinity DataIC50: 63nMAssay Description:Inhibition of SARS coronavirus 3C-like proteaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM50208939(5-chloropyridin-3-yl 1H-indole-2-carboxylate | 5-c...)
Affinity DataIC50: 65nMAssay Description:Inhibition of SARS coronavirus 3C-like proteaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM50208941(5-chloropyridin-3-yl benzo[b]thiophene-2-carboxyla...)
Affinity DataIC50: 95nMAssay Description:Inhibition of SARS coronavirus 3C-like proteaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM582031(US11518759, Compound 4 | Preparation of pyrrolidin...)
Affinity DataIC50: 100nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM582032(US11518759, Compound 5 | Preparation of (2S,4R)-1-...)
Affinity DataIC50: 100nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM582033(US11518759, Compound 6 | Preparation of (2S,4R)-1-...)
Affinity DataIC50: 100nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM582035(US11518759, Compound 8 | Preparation of (2S,4R)-1-...)
Affinity DataIC50: 100nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM582036(US11518759, Compound 9 | Preparation of (2S,4R)-1-...)
Affinity DataIC50: 100nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM699309(US20240327458, Compound 8b)
Affinity DataIC50: 138nMAssay Description:An objective of this experiment is to detect the in vitro inhibitory activity against Mpro of the compound of the present disclosure.Experimental mat...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM50007791(CHEMBL3233815 | med.21724, Compound 168)
Affinity DataIC50: 150nMAssay Description:This is a review article.More data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM496258(JOH-MSK-46727e7b-1 | CVD-0013146)
Affinity DataIC50: 161nMAssay Description:Inhibition of SARS-CoV N-terminal 6His-SUMO-tagged 3CL protease expressed in Escherichia coli BL21 (DE3) using Dabcyl-KTSAVLQSGFRKM-Glu-Edans fluorog...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM50620678(CHEMBL5436771)
Affinity DataIC50: 165nMAssay Description:Inhibition of SARS-CoV N-terminal 6His-SUMO-tagged 3CL protease expressed in Escherichia coli BL21 (DE3) using Dabcyl-KTSAVLQSGFRKM-Glu-Edans fluorog...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM50208943(5-chloropyridin-3-yl benzofuran-2-carboxylate | CH...)
Affinity DataIC50: 170nMAssay Description:Inhibition of SARS coronavirus 3C-like proteaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM699303(Synthesis of N-((3S, 15S, 18aS, 19aR, 19bS)-3-cyan...)
Affinity DataIC50: 254nMAssay Description:An objective of this experiment is to detect the in vitro inhibitory activity against Mpro of the compound of the present disclosure.Experimental mat...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM50208938(5-chloropyridin-3-yl thiazole-4-carboxylate | 5-ch...)
Affinity DataIC50: 270nMAssay Description:Inhibition of SARS coronavirus 3C-like proteaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM50007789(CHEMBL1173044 | GRL-0667 | N-(2H-1,3-benzodioxol-5...)
Affinity DataIC50: 320nMAssay Description:This is a review article.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM50208944(5-chloropyridin-3-yl-3-methoxybenzoate | 5-chlorop...)
Affinity DataIC50: 340nMAssay Description:Inhibition of SARS coronavirus 3C-like proteaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM50055218(1-(2-naphthlmethyl) isatin-5-carboxamide | 1-Napht...)
Affinity DataIC50: 370nMAssay Description:Inhibition of SARS CoV 3C-like proteaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM699306(Synthesis of N-((3S, 16S, 19aS, 20aR, 20bS)-3-cyan...)
Affinity DataIC50: 379nMAssay Description:An objective of this experiment is to detect the in vitro inhibitory activity against Mpro of the compound of the present disclosure.Experimental mat...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM50620674(CHEMBL4590273)
Affinity DataIC50: 383nMAssay Description:Inhibition of SARS-CoV N-terminal 6His-SUMO-tagged 3CL protease expressed in Escherichia coli BL21 (DE3) using Dabcyl-KTSAVLQSGFRKM-Glu-Edans fluorog...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM50007788(CHEMBL3233809 | med.21724, Compound 167)
Affinity DataIC50: 390nMAssay Description:This is a review article.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM699305(Synthesis of N-((3S, 15S, 18aS, 19aR, 19bS, Z)-3-c...)
Affinity DataIC50: 411nMAssay Description:An objective of this experiment is to detect the in vitro inhibitory activity against Mpro of the compound of the present disclosure.Experimental mat...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM31531(Substituted Benzamide Derivative, 2 | med.21724, C...)
Affinity DataIC50: 460nMAssay Description:This is a review article.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM50007790(CHEMBL3233814 | med.21724, Compound 169)
Affinity DataIC50: 490nMAssay Description:This is a review article.More data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM582030(US11518759, Compound 3 | Preparation of (2S,4R)-1-...)
Affinity DataIC50: 550nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM582034(US11518759, Compound 7)
Affinity DataIC50: 550nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM582028(US11518759, Compound 1)
Affinity DataIC50: 550nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM582029(US11518759, Compound 2 | Preparation of (2S,4R)-1-...)
Affinity DataIC50: 550nMAssay Description:The inhibitory activity of the compounds against SARS-CoV-2 3CLpro was determined using fluorescence resonance energy transfer.10 μL of the comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM31523(Naphthalene and Benzamide Derivative, 24 | med.217...)
Affinity DataIC50: 560nMAssay Description:This is a review article.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM154574(N-(2H-1,3-benzodioxol-5-ylmethyl)-1-[(1S)-1-(napht...)
Affinity DataIC50: 560nMAssay Description:This is a review article.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM31524(Naphthalene and Benzamide Derivative, 25 | 5-amino...)
Affinity DataIC50: 600nMAssay Description:This is a review article.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM51317(1,6-dimethylnaphtho[1,2-g][1]benzofuran-10,11-dion...)
Affinity DataIC50: 700nMAssay Description:Inhibition of SARS-CoV PLpro deubiququitination expressed in Escherichia coli BL21 (DE3) using Arg-Leu-Arg-Gly-Gly-AMC as substrate by fluorescence a...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM53072(3-Allyl-5-(3-ethyl-3H-benzothiazol-2-ylidene)-2-th...)
Affinity DataIC50: 800nMAssay Description:Inhibition of SARS-CoV PLpro expressed in Escherichia coli BL21 (DE3) using Arg-Leu-Arg-Gly-Gly-AMC as substrate preincubated for 30 mins by fluoresc...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM83922(cid_164676 | 1,6,6-trimethyl-8,9-dihydro-7H-naphth...)
Affinity DataIC50: 800nMAssay Description:This is a review article.More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM419127(3CLpro inhibitor 6e)
Affinity DataIC50: 900nMAssay Description:The expression and purification of the 3CLpro of MERS-CoV and SARS-CoV were performed by a standard method described previously by our lab (11, 19, 2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM50167307(1-Benzo[b]thiophen-2-ylmethyl-5-iodo-1H-indole-2,3...)
Affinity DataIC50: 950nMAssay Description:In vitro inhibitory concentration against SARS coronavirus main protease (SARS CoV 3C-like protease)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM50167309(1-Benzo[b]thiophen-2-ylmethyl-7-bromo-1H-indole-2,...)
Affinity DataIC50: 980nMAssay Description:In vitro inhibitory concentration SARS coronavirus main protease (SARS CoV 3C-like protease) More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM419128(3CLpro inhibitor 7e)
Affinity DataIC50: 1.00E+3nMAssay Description:The expression and purification of the 3CLpro of MERS-CoV and SARS-CoV were performed by a standard method described previously by our lab (11, 19, 2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM419131(3CLpro inhibitor 6j | 3CLpro inhibitor 7j)
Affinity DataIC50: 1.10E+3nMAssay Description:The expression and purification of the 3CLpro of MERS-CoV and SARS-CoV were performed by a standard method described previously by our lab (11, 19, 2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM50423877(Dihydrotanshinone I | DIHYDROTANSHINONE | acs.jmed...)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of SARS-CoV PLpro deubiququitination expressed in Escherichia coli BL21 (DE3) using Arg-Leu-Arg-Gly-Gly-AMC as substrate by fluorescence a...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM419131(3CLpro inhibitor 6j | 3CLpro inhibitor 7j)
Affinity DataIC50: 1.20E+3nMAssay Description:The expression and purification of the 3CLpro of MERS-CoV and SARS-CoV were performed by a standard method described previously by our lab (11, 19, 2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM31530(Substituted Benzamide Derivative, 49 | 2-methyl-5-...)
Affinity DataIC50: 1.23E+3nMAssay Description:This is a review article.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM429329(jm5b01461, Compound 146-(R) | acs.jmedchem.1c00409...)
Affinity DataIC50: 1.50E+3nMAssay Description:This is a review article.More data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM83922(cid_164676 | 1,6,6-trimethyl-8,9-dihydro-7H-naphth...)
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of SARS-CoV PLpro expressed in Escherichia coli BL21 (DE3) using Arg-Leu-Arg-Gly-Gly-AMC as substrate preincubated for 30 mins by fluoresc...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM419124(3CLpro inhibitor 6c)
Affinity DataIC50: 1.70E+3nMAssay Description:The expression and purification of the 3CLpro of MERS-CoV and SARS-CoV were performed by a standard method described previously by our lab (11, 19, 2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM419126(3CLpro inhibitor 7c)
Affinity DataIC50: 1.70E+3nMAssay Description:The expression and purification of the 3CLpro of MERS-CoV and SARS-CoV were performed by a standard method described previously by our lab (11, 19, 2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
PubMed
TargetReplicase polyprotein 1a(SARS-CoV)
TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED

US Patent
LigandPNGBDBM50167306(1-Benzo[b]thiophen-2-ylmethyl-7-nitro-1H-indole-2,...)
Affinity DataIC50: 2.00E+3nMAssay Description:In vitro inhibitory concentration against SARS coronavirus main protease (SARS CoV 3C-like protease)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Displayed 1 to 50 (of 464 total ) | Next | Last >>
Jump to: